Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study
Objective. To determine factors associated with single antiplatelet (SAP) or dual antiplatelet (DAP) therapy and anticoagulants (AC) use in hospital and after discharge among patients with acute coronary syndrome (ACS). Methods. We evaluated 5,294 ACS patients in the Intermountain Heart Collaborativ...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2015/270508 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554577193336832 |
|---|---|
| author | Stacey Knight Winslow Klaskala Scott C. Woller Benjamin D. Horne T. Jared Bunch Viet T. Le Roger M. Mills Joseph B. Muhlestein |
| author_facet | Stacey Knight Winslow Klaskala Scott C. Woller Benjamin D. Horne T. Jared Bunch Viet T. Le Roger M. Mills Joseph B. Muhlestein |
| author_sort | Stacey Knight |
| collection | DOAJ |
| description | Objective. To determine factors associated with single antiplatelet (SAP) or dual antiplatelet (DAP) therapy and anticoagulants (AC) use in hospital and after discharge among patients with acute coronary syndrome (ACS). Methods. We evaluated 5,294 ACS patients in the Intermountain Heart Collaborative Study from 2004 to 2009. Multivariable logistic regressions were used to determine predictors of AC or AP use. Results. In hospital, 99% received an AC, 79% DAP, and 19% SAP; 78% had DAP + AC. Coronary stents were the strongest predictors of DAP use in hospital compared to SAP (P<0.001). After discharge, 77% received DAP, 20% SAP, and 9% AC; 5% had DAP + AC. DAP compared to SAP was less likely for patients on AC (odds ratio [OR] = 0.30, P<0.0001) after discharge. Placement of a stent increased the likelihood of DAP (bare metal: OR = 54.8, P<0.0001; drug eluting: OR = 59.4, P<0.0001). 923 had atrial fibrillation and 337 had a history of venous thromboembolism; these patients had increased use of AC (29% and 40%, resp.). Conclusion. While in-hospital use of AC was nearly universal, postdischarge AC use was rare. Concern for providing the best antithrombotic therapy, while maintaining an acceptable bleeding risk, may explain the selection decisions. |
| format | Article |
| id | doaj-art-887b45bf01804800b1e409c8edf85068 |
| institution | Kabale University |
| issn | 2090-8016 2090-0597 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiology Research and Practice |
| spelling | doaj-art-887b45bf01804800b1e409c8edf850682025-02-03T05:51:09ZengWileyCardiology Research and Practice2090-80162090-05972015-01-01201510.1155/2015/270508270508Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative StudyStacey Knight0Winslow Klaskala1Scott C. Woller2Benjamin D. Horne3T. Jared Bunch4Viet T. Le5Roger M. Mills6Joseph B. Muhlestein7Intermountain Medical Center, Intermountain Heart Institute, 5121 S. Cottonwood Street, Murray, UT 84107, USAJanssen Research and Development, Raritan, NJ 08869, USAIntermountain Medical Center, Intermountain Heart Institute, 5121 S. Cottonwood Street, Murray, UT 84107, USAIntermountain Medical Center, Intermountain Heart Institute, 5121 S. Cottonwood Street, Murray, UT 84107, USAIntermountain Medical Center, Intermountain Heart Institute, 5121 S. Cottonwood Street, Murray, UT 84107, USAIntermountain Medical Center, Intermountain Heart Institute, 5121 S. Cottonwood Street, Murray, UT 84107, USAJanssen Research and Development, Raritan, NJ 08869, USAIntermountain Medical Center, Intermountain Heart Institute, 5121 S. Cottonwood Street, Murray, UT 84107, USAObjective. To determine factors associated with single antiplatelet (SAP) or dual antiplatelet (DAP) therapy and anticoagulants (AC) use in hospital and after discharge among patients with acute coronary syndrome (ACS). Methods. We evaluated 5,294 ACS patients in the Intermountain Heart Collaborative Study from 2004 to 2009. Multivariable logistic regressions were used to determine predictors of AC or AP use. Results. In hospital, 99% received an AC, 79% DAP, and 19% SAP; 78% had DAP + AC. Coronary stents were the strongest predictors of DAP use in hospital compared to SAP (P<0.001). After discharge, 77% received DAP, 20% SAP, and 9% AC; 5% had DAP + AC. DAP compared to SAP was less likely for patients on AC (odds ratio [OR] = 0.30, P<0.0001) after discharge. Placement of a stent increased the likelihood of DAP (bare metal: OR = 54.8, P<0.0001; drug eluting: OR = 59.4, P<0.0001). 923 had atrial fibrillation and 337 had a history of venous thromboembolism; these patients had increased use of AC (29% and 40%, resp.). Conclusion. While in-hospital use of AC was nearly universal, postdischarge AC use was rare. Concern for providing the best antithrombotic therapy, while maintaining an acceptable bleeding risk, may explain the selection decisions.http://dx.doi.org/10.1155/2015/270508 |
| spellingShingle | Stacey Knight Winslow Klaskala Scott C. Woller Benjamin D. Horne T. Jared Bunch Viet T. Le Roger M. Mills Joseph B. Muhlestein Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study Cardiology Research and Practice |
| title | Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study |
| title_full | Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study |
| title_fullStr | Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study |
| title_full_unstemmed | Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study |
| title_short | Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study |
| title_sort | antithrombotic therapy in patients with acute coronary syndrome in the intermountain heart collaborative study |
| url | http://dx.doi.org/10.1155/2015/270508 |
| work_keys_str_mv | AT staceyknight antithrombotictherapyinpatientswithacutecoronarysyndromeintheintermountainheartcollaborativestudy AT winslowklaskala antithrombotictherapyinpatientswithacutecoronarysyndromeintheintermountainheartcollaborativestudy AT scottcwoller antithrombotictherapyinpatientswithacutecoronarysyndromeintheintermountainheartcollaborativestudy AT benjamindhorne antithrombotictherapyinpatientswithacutecoronarysyndromeintheintermountainheartcollaborativestudy AT tjaredbunch antithrombotictherapyinpatientswithacutecoronarysyndromeintheintermountainheartcollaborativestudy AT viettle antithrombotictherapyinpatientswithacutecoronarysyndromeintheintermountainheartcollaborativestudy AT rogermmills antithrombotictherapyinpatientswithacutecoronarysyndromeintheintermountainheartcollaborativestudy AT josephbmuhlestein antithrombotictherapyinpatientswithacutecoronarysyndromeintheintermountainheartcollaborativestudy |